List of bibliographic references
Number of relevant bibliographic references: 6.
List of associated KwdEn.i
Nombre de documents | Descripteur |
5 | Arthritis rheum |
5 | Rheum |
5 | Rheumatology |
4 | Ankylosing |
4 | Ankylosing spondylitis |
4 | Chronic |
4 | Heijde |
4 | Nsaid |
4 | Spondylitis |
3 | AS, ankylosing spondylitis |
3 | Arthritis |
3 | Asas |
3 | Braun |
3 | Clinical trials |
3 | Expert opinion |
3 | Infliximab |
3 | Methotrexate |
3 | NSAIDs, non-steroidal anti-inflammatory drugs |
3 | Physical function |
3 | Randomized |
3 | Rheumatoid |
3 | Rheumatoid arthritis |
3 | Rheumatol |
3 | Side effects |
3 | Spinal |
3 | Spinal pain |
3 | Systematic review |
3 | TNF, tumour necrosis factor |
3 | Toxicity |
3 | ankylosing spondylitis |
2 | ASAS, ASsessment in AS |
2 | Active ankylosing spondylitis |
2 | Active disease |
2 | Adverse effects |
2 | Antirheumatic drugs |
2 | Arthroplasty |
2 | Asas recommendations |
2 | Blocker |
2 | CI, confidence interval |
2 | Calin |
2 | Cardiovascular |
2 | Clinical response |
2 | Cochrane database syst |
2 | Cohort |
2 | Corticosteroid |
2 | Cost effectiveness |
2 | Coxibs |
2 | DMARDs, disease modifying antirheumatic drugs |
2 | Disease activity |
2 | Dougados |
2 | ES, effect size |
2 | Effect size |
2 | Erythrocyte sedimentation rate |
2 | Etanercept |
2 | Home exercise |
2 | Incremental cost effectiveness ratio |
2 | MRI, magnetic resonance imaging |
2 | Magnetic resonance imaging |
2 | Necrosis |
2 | Pain relief |
2 | Peripheral arthritis |
2 | Physiotherapy |
2 | Placebo |
2 | RCT, randomised controlled trial |
2 | Randomised |
2 | Rcts |
2 | Recommendation |
2 | Relative risk |
2 | Rheumatologist |
2 | Study design |
2 | Sulfasalazine |
2 | Systematic reviews |
2 | Systemic lupus erythematosus |
2 | Tumour necrosis factor |
2 | VAS, visual analogue scale |
2 | Visual analogue scale |
2 | Zochling |
2 | evidence based medicine |
1 | ASAS |
1 | ASAS, ASsessment in Ankylosing Spondylitis |
1 | ASAS-IC, ASsessment in Ankylosing Spondylitis improvement criteria |
1 | Absolute change scores |
1 | Absolute improvement |
1 | American college |
1 | Andersson lesion |
1 | Ankylosing spondylitis improvement criteria |
1 | Antibody infliximab |
1 | Antinuclear antibodies |
1 | Asas core |
1 | Asas improvement criteria |
1 | Axial |
1 | Axial disease |
1 | BASDAI, Bath Ankylosing Spondylitis Disease Activity Index |
1 | Basdai |
1 | Basdai criterion |
1 | Basdai score |
1 | Basdai scores |
1 | Bath ankylosing spondylitis |
1 | Bath ankylosing spondylitis disease activity index |
1 | Beneficial effect |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Allemagne/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i -k "D. Van Der Heijde"
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i \
-Sk "D. Van Der Heijde" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Allemagne/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Allemagne
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= D. Van Der Heijde
}}
| This area was generated with Dilib version V0.6.33. Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024 | |